4/A//SEC Filing
Hebert Robert P 4/A
Accession 0001364804-09-000005
CIK 0001418919other
Filed
Sep 29, 8:00 PM ET
Accepted
Sep 30, 1:57 PM ET
Size
8.5 KB
Accession
0001364804-09-000005
Insider Transaction Report
Form 4/AAmended
Hebert Robert P
Chief Financial Officer
Transactions
- Award
Right to Purchase
2009-09-29+2,105→ 2,105 totalExercise: $10.00Exp: 2019-09-29→ Common Stock, $0.01 par value (2,105 underlying) - Award
Restricted Stock Units
2009-09-29+402→ 402 total→ Common Stock, $0.01 par value (402 underlying)
Footnotes (4)
- [F1]The original report on Form 4 filed on 9/30/2009 is being amended to correct the amount of securities beneficially owned following the reported transaction.
- [F2]Options were granted under terms of the Company's Amended and Restated 2008 Equity Incentive Plan. Grant become exercisable in three equal installments on 9/29/2010, 9/29/2011 and 9/29/2012.
- [F3]Each restricted stock unit represents a contingent right to receive one share of CPEX Pharmaceuticals, Inc. Common Stock, $0.01 par value.
- [F4]Restricted stock units were granted under terms of the Company's Amended and Restated 2008 Equity Incentive Plan.Units vest, and will be issued to the reporting person in three equal installments on 9/29/2010, 9/29/2011 and 9/29/2012.
Documents
Issuer
CPEX Pharmaceuticals, Inc.
CIK 0001418919
Entity typeother
Related Parties
1- filerCIK 0001364804
Filing Metadata
- Form type
- 4/A
- Filed
- Sep 29, 8:00 PM ET
- Accepted
- Sep 30, 1:57 PM ET
- Size
- 8.5 KB